-
1
-
-
0035571073
-
3 mRNA in rat cardiac fibroblasts via destabilization
-
Abdelaziz, N., F. Colombo, I. Mercier and A. Calderone. Nitric oxide attenuates the expression of transforming growth factor-beta(3) mRNA in rat cardiac fibroblasts via destabilization. Hypertension 38: 261-266, 2001. (Pubitemid 34224755)
-
(2001)
Hypertension
, vol.38
, Issue.2
, pp. 261-266
-
-
Abdelaziz, N.1
Colombo, F.2
Mercier, I.3
Calderone, A.4
-
2
-
-
0032519668
-
Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts
-
Calderone, A., C.M. Thaik, N. Takahashi, D.L. Chang and W.S. Colucci. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J. Clin. Invest. 101: 812-818, 1998. (Pubitemid 28096078)
-
(1998)
Journal of Clinical Investigation
, vol.101
, Issue.4
, pp. 812-818
-
-
Calderone, A.1
Thaik, C.M.2
Takahashi, N.3
Chang, D.L.F.4
Colucci, W.S.5
-
3
-
-
0242721091
-
Involvement of Reactive Oxygen Species in Angiotensin II-Induced Endothelin-1 Gene Expression in Rat Cardiac Fibroblasts
-
DOI 10.1016/j.jacc.2003.06.010
-
Cheng, T.H., P.Y. Cheng, N.L. Shih, I.B. Chen, D.L. Wang and JJ. Chen. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibro-blasts. J. Am. Coll. Cardiol. 42: 1845-1854, 2003. (Pubitemid 37433668)
-
(2003)
Journal of the American College of Cardiology
, vol.42
, Issue.10
, pp. 1845-1854
-
-
Cheng, T.-H.1
Cheng, P.-Y.2
Shih, N.-L.3
Chen, I.-B.4
Wang, D.L.5
Chen, J.-J.6
-
4
-
-
34250814485
-
Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis
-
DOI 10.1016/j.ejphar.2007.04.031, PII S0014299907004694
-
Fu, J., H. Huang, J. Liu, R. Pi, J. Chen and P. Liu. Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur. J. Pharmacol. 568: 213-221, 2007. (Pubitemid 46976900)
-
(2007)
European Journal of Pharmacology
, vol.568
, Issue.1-3
, pp. 213-221
-
-
Fu, J.1
Huang, H.2
Liu, J.3
Pi, R.4
Chen, J.5
Liu, P.6
-
5
-
-
38049051048
-
Tanshinone IIA Protects Neonatal Rat Cardiomyocytes from Adriamycin-induced Apoptosis
-
Yang, R. Pi, R. Li, P. Wang, H. Zhang, K. Le, S. Chen and P. Liu. Tanshinone IIA Protects Neonatal Rat Cardiomyocytes from Adriamycin-induced Apoptosis. Transl. Res. 151: 79-87, 2008.
-
(2008)
Transl. Res.
, vol.151
, pp. 79-87
-
-
Yang1
Pi, R.2
Li, R.3
Wang, P.4
Zhang, H.5
Le, K.6
Chen, S.7
Liu, P.8
-
6
-
-
34447133157
-
Investigation of the effect of tanshinone IIA on nitric oxide production in human vascular endothelial cells by fluorescence imaging
-
DOI 10.1016/j.saa.2007.01.029, PII S1386142507000649
-
Huang, KJ., H. Wang, W.Z. Xie and H.S. Zhang. Investigation of the effect of tanshinone IIA on nitric oxide production in human vascular endothelial cells by fluorescence imaging. Spectrochim. Acta A-M 68: 1180-1186, 2007. (Pubitemid 350161386)
-
(2007)
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
, vol.68
, Issue.5
, pp. 1180-1186
-
-
Huang, K.-J.1
Wang, H.2
Xie, W.-Z.3
Zhang, H.-S.4
-
7
-
-
33750327341
-
Protective effect of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism
-
DOI 10.1016/j.jep.2006.05.004, PII S0378874106002534
-
Lin, R., W.R. Wang, J.T. Liu, G.D. Yang and CJ. Han. Protective effect of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism. J. Ethno-pharmacol. 108: 217-222, 2006. (Pubitemid 44635028)
-
(2006)
Journal of Ethnopharmacology
, vol.108
, Issue.2
, pp. 217-222
-
-
Lin, R.1
Wang, W.-R.2
Liu, J.-T.3
Yang, G.-D.4
Han, C.-J.5
-
8
-
-
37549057326
-
Enhanced antioxidant bioactivity of Salvia miltiorrhiza (Danshen) products prepared using nanotechnology
-
Liu, J.R., G.F. Chen, H.N. Shih and P.C. Kuo. Enhanced antioxidant bioactivity of Salvia miltiorrhiza (Danshen) products prepared using nanotechnology. Phytomedicine 15: 23-30, 2008.
-
(2008)
Phytomedicine
, vol.15
, pp. 23-30
-
-
Liu, J.R.1
Chen, G.F.2
Shih, H.N.3
Kuo, P.C.4
-
9
-
-
67249152096
-
Cardiac fibroblasts: At the heart of myocardial remodeling
-
Porter, K.E. and NA. Turner. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 123: 255-278, 2009.
-
(2009)
Pharmacol. Ther.
, vol.123
, pp. 255-278
-
-
Porter, K.E.1
Turner, N.A.2
-
10
-
-
77950363801
-
Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure
-
Rehsia, N.S. and N.S. Dhalla. Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure. Heart Fail. Rev. 15: 85-101, 2010.
-
(2010)
Heart Fail. Rev.
, vol.15
, pp. 85-101
-
-
Rehsia, N.S.1
Dhalla, N.S.2
-
11
-
-
0034032576
-
Angiotensin II, adhesion, and cardiac fibrosis
-
DOI 10.1016/S0008-6363(00)00044-4, PII S0008636300000444
-
Schnee, J.M. and W.A. Hsueh. Angiotensin II, adhesion, and cardiac fibrosis. Cardiovasc. Res. 46: 264-268, 2000. (Pubitemid 30204598)
-
(2000)
Cardiovascular Research
, vol.46
, Issue.2
, pp. 264-268
-
-
Schnee, J.M.1
Hsueh, W.A.2
-
12
-
-
14844309367
-
Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction
-
DOI 10.1016/j.lfs.2004.11.028
-
Smith, R.S., Jr., J. Agata, C.F. Xia, L. Chao and J. Chao. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sci. 76: 2457-2471, 2005. (Pubitemid 40341962)
-
(2005)
Life Sciences
, vol.76
, Issue.21
, pp. 2457-2471
-
-
Smith Jr., R.S.1
Agata, J.2
Xia, C.-F.3
Chao, L.4
Chao, J.5
-
13
-
-
48049120166
-
Tanshinone IIA: A new activator of human cardiac KCNQ1/KCNE1 (I(Ks)) potassium channels
-
Sun, D.D., H.C. Wang, X.B. Wang, Y. Luo, Z.X. Jin, Z.C Li, G.R. Li and M.Q. Dong. Tanshinone IIA: a new activator of human cardiac KCNQ1/KCNE1 (I(Ks)) potassium channels. Eur. J. Pharmacol. 590: 317-321, 2008.
-
(2008)
Eur. J. Pharmacol.
, vol.590
, pp. 317-321
-
-
Sun, D.D.1
Wang, H.C.2
Wang, X.B.3
Luo, Y.4
Jin, Z.X.5
Li, Z.C.6
Li, G.R.7
Dong, M.Q.8
-
14
-
-
45049084732
-
The chemical biology of nitric oxide: Implications in cellular signaling
-
Thomas, D.D., LA. Ridnour, J.S. Isenberg, W. Flores-Santana, C.H. Switzer, S. Donzelli, P. Hussain, C Vecoli, N. Paolocci, S. Ambs, CA. Colton, C.C. Harris, D.D. Roberts and DA. Wink. The chemical biology of nitric oxide: implications in cellular signaling. Free Radic. Biol. Med. 45: 18-31, 2008.
-
(2008)
Free Radic. Biol. Med.
, vol.45
, pp. 18-31
-
-
Thomas, D.D.1
Ridnour, L.A.2
Isenberg, J.S.3
Flores-Santana, W.4
Switzer, C.H.5
Donzelli, S.6
Hussain, P.7
Vecoli, C.8
Paolocci, N.9
Ambs, S.10
Colton, C.A.11
Harris, C.C.12
Roberts, D.D.13
Wink, D.A.14
-
15
-
-
68549085074
-
Tanshinone II(A) elicited vasodilation in rat coronary arteriole: Roles of nitric oxide and potassium channels
-
Wu, G.B., E.X. Zhou and D.X. Qing. Tanshinone II(A) elicited vasodilation in rat coronary arteriole: roles of nitric oxide and potassium channels. Eur. J. Pharmacol. 617: 102-107, 2009.
-
(2009)
Eur. J. Pharmacol.
, vol.617
, pp. 102-107
-
-
Wu, G.B.1
Zhou, E.X.2
Qing, D.X.3
-
16
-
-
0027131744
-
Effect of sodium tanshinone IIA sulfonate in the rabbit myocardium and on human cardiomyocytes and vascular endothelial cells
-
DOI 10.1016/0006-2952(93)90624-6
-
Wu, T.W., L.H. Zeng, K.P. Fung, J. Wu, H. Pang, AA. Grey, R.D. Weisel and JY. Wang. Effect of sodium tanshinone IIA sulfonate in the rabbit myocardium and on human cardiomyocytes and vascular endothelial cells. Biochem. Pharmacol. 46: 2327-2332, 1993. (Pubitemid 24012326)
-
(1993)
Biochemical Pharmacology
, vol.46
, Issue.12
, pp. 2327-2332
-
-
Wu, T.-W.1
Zeng, L.-H.2
Fung, K.-P.3
Wu, J.4
Pang, H.5
Grey, A.A.6
Weisel, R.D.7
Wang, J.Y.8
-
17
-
-
70349241906
-
Cardioprotective effects of tanshinone IIA on myocardial ischemia injury in rats
-
Xu, W., J. Yang and L.M. Wu. Cardioprotective effects of tanshinone IIA on myocardial ischemia injury in rats. Pharmazie 64: 332-336, 2009.
-
(2009)
Pharmazie
, vol.64
, pp. 332-336
-
-
Xu, W.1
Yang, J.2
Wu, L.M.3
-
18
-
-
68049097297
-
Sodium tanshinone IIA sulfonate attenuates angiotensin II-induced collagen type i expression in cardiac fibroblasts in vitro
-
Yang, L., XJ. Zou, X. Gao, H. Chen, J.L. Luo, Z.H. Wang, Q.S. Liang and GT. Yang. Sodium tanshinone IIA sulfonate attenuates angiotensin II-induced collagen type I expression in cardiac fibroblasts in vitro. Exp. Mol. Med. 41: 508-516, 2009.
-
(2009)
Exp. Mol. Med.
, vol.41
, pp. 508-516
-
-
Yang, L.1
Zou, X.J.2
Gao, X.3
Chen, H.4
Luo, J.L.5
Wang, Z.H.6
Liang, Q.S.7
Yang, G.T.8
-
19
-
-
42449089893
-
Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation
-
DOI 10.1097/FJC.0b013e3181671439, PII 0000534420080400000008
-
Yang, R., A. Liu, X. Ma, L. Li, D. Su and J. Liu. Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation. J. Cardiovasc. Pharmacol. 51: 396-401, 2008. (Pubitemid 351572239)
-
(2008)
Journal of Cardiovascular Pharmacology
, vol.51
, Issue.4
, pp. 396-401
-
-
Yang, R.1
Liu, A.2
Ma, X.3
Li, L.4
Su, D.5
Liu, J.6
-
20
-
-
0031656261
-
2 in angiotensin II-induced vascular hypertrophy
-
Zafari, A.M., M. Ushio-Fukai, M. Akers, Q. Yin, A. Shah, D.G. Harrison, W.R. Taylor and K.K. Griendling. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 32: 488-495, 1998. (Pubitemid 28429138)
-
(1998)
Hypertension
, vol.32
, Issue.3
, pp. 488-495
-
-
Zafari, A.M.1
Ushio-Fukai, M.2
Akers, M.3
Yin, Q.4
Shah, A.5
Harrison, D.G.6
Taylor, W.R.7
Griendling, K.K.8
-
21
-
-
27844511101
-
Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
-
DOI 10.1177/0091270005282630
-
Zhou, L., Z. Zuo and M.S. Chow. Danshen: an overview of its chemistry, pharmacology, pharma-cokinetics, and clinical use. J. Clin. Pharmacol. 45: 1345-1359, 2005. (Pubitemid 41643896)
-
(2005)
Journal of Clinical Pharmacology
, vol.45
, Issue.12
, pp. 1345-1359
-
-
Zhou, L.1
Zuo, Z.2
Chow, M.S.S.3
|